[PRESS RELEASE] – NEW YORK, Sept. 23, 2025 – Mamedica, the U.Okay.’s main and most-trusted supplier of cannabis-based prescription medications, introduced a £4.5 million investment spherical led through Casa Verde, the U.S.-based cannabis-focused project capital company.
Casa Verde has sponsored primary hashish corporations, together with Dutchie, Metrc and Leaflink, in the USA, and holds Ecu positions in Cansativa and Sanity Staff. The brand new capital will likely be used to scale Mamedica’s operations through optimizing its in-house provide chain for potency and continuity of care, increasing get right of entry to via a much broader scientific community, advancing its proprietary electronic well being care platform with enhanced automation and compliance functions, and using schooling across the integration of clinical hashish into mainstream well being care.
Introduced in 2022 through founder and CEO Jon Robson, Mamedica supplies specialist remedy for power and neurological stipulations, together with ache, anxiousness, ADHD and melancholy. Its electronic fashion permits far flung consultations with specialist clinicians, with medicine delivered national through safe next-day courier.
Since its inception, Mamedica has handled over 10,000 sufferers, with roughly 7,500 actively beneath care, and round 10% month-on-month expansion in preliminary consultations. The corporate recorded 1,250% affected person expansion in 2023 and 154% in 2024 and expects to double affected person numbers every year because the U.Okay. clinical hashish business approaches £1 billion in annual gross sales through the tip of 2028.
“We are excited to spouse with Mamedica because the U.Okay. hashish marketplace enters a length of speedy expansion,” stated Karan Wadhera, managing spouse at Casa Verde. “Mamedica’s digital-first, patient-centric fashion units the usual for care within the U.Okay. and provides a blueprint for broader Ecu enlargement.”
“This investment marks a pivotal milestone in Mamedica’s challenge to turn out to be affected person care within the U.Okay.,” Robson stated. “The backing of Casa Verde and our non-public traders validates our means and permits us to boost up get right of entry to to top of the range, regulated remedy.”
